Debt investors
Explore Novonesis' EMTN program and related information.
EMTN program 2026
On March 10 2026, Novonesis established a Euro Medium Term Note program (the “Program”) listed on the Luxembourg Stock Exchange.
You can download the related documents here:
Issuer: Novozymes A/S
Program size: EUR 4,000,000,000
Arranger: BNP Paribas
Dealers: BNP Paribas, BofA Securities, Citi, Danske Bank, HSBC, Nordea, Nykredit and SEB
Outstanding bonds
| Issuer | Amount (millions) | Currency | Coupon | Issue date: | Maturity date | ISIN |
|---|---|---|---|---|---|---|
| Novozymes A/S | 500 | EUR | 3.25% | March 19, 2026 | March 19, 2030 | XS3320129599 |
| Novozymes A/S | 600 | EUR | 3.625% | March 19, 2026 | March 19, 2033 | XS3320130175 |
| Novozymes A/S | 600 | EUR | 4.00% | March 19, 2026 | March 19, 2037 | XS3320130258 |
Credit ratings
| Rating agency | Corporate rating | Outlook | Download |
|---|---|---|---|
| S&P Global Ratings | A- | Stable |
Whether you're a shareholder or an investment professional, we're here to help.